Erschienen in:
01.06.2019 | Letter to the Editor
Malignant syndrome triggered by influenza A virus infection in a patient with Parkinson’s disease with improvement after intravenous peramivir treatment
verfasst von:
Kosuke Matsuzono, Masamichi Baba, Goro Imai, Hiroaki Imai, Shigeru Fujimoto
Erschienen in:
Neurological Sciences
|
Ausgabe 6/2019
Einloggen, um Zugang zu erhalten
Excerpt
Malignant syndrome, also called parkinsonism-hyperpyrexia syndrome, is a rare medical emergency in patients with Parkinson’s disease (PD). The precipitating events that trigger malignant syndrome in patients with PD are anti-parkinsonian drug withdrawal and stress-related factors [
1,
2]. Infection is a major cause of malignant syndrome, and fever is considered the trigger [
1]. However, the relationship among malignant syndrome, influenza virus infection, and treatment for influenza virus remains unclear. We herein report a case involving a man with PD who developed malignant syndrome secondary to influenza A virus infection but improved after intravenous peramivir treatment without dantrolene. …